AllianceBernstein’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $48.9K | Buy |
97,038
+13,903
| +17% | +$7K | ﹤0.01% | 3210 |
|
2025
Q1 | $651K | Sell |
83,135
-13,575
| -14% | -$106K | ﹤0.01% | 2447 |
|
2024
Q4 | $1.02M | Buy |
96,710
+31,588
| +49% | +$332K | ﹤0.01% | 2319 |
|
2024
Q3 | $854K | Sell |
65,122
-36,102
| -36% | -$473K | ﹤0.01% | 2400 |
|
2024
Q2 | $322M | Buy |
+101,224
| New | +$322M | 0.11% | 151 |
|
2016
Q1 | – | Sell |
-876,002
| Closed | -$10.7M | – | 2903 |
|
2015
Q4 | $10.7M | Buy |
876,002
+87,882
| +11% | +$1.07M | 0.01% | 846 |
|
2015
Q3 | $12.9M | Buy |
+788,120
| New | +$12.9M | 0.01% | 813 |
|